7-86880476-T-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001142749.3(ELAPOR2):āc.3085A>Gā(p.Ile1029Val) variant causes a missense change. The variant allele was found at a frequency of 0.0000454 in 1,608,050 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000072 ( 0 hom., cov: 32)
Exomes š: 0.000043 ( 0 hom. )
Consequence
ELAPOR2
NM_001142749.3 missense
NM_001142749.3 missense
Scores
4
15
Clinical Significance
Conservation
PhyloP100: 5.43
Genes affected
ELAPOR2 (HGNC:21945): (endosome-lysosome associated apoptosis and autophagy regulator family member 2) Predicted to enable BMP receptor binding activity. Predicted to be involved in negative regulation of nervous system development; positive regulation of BMP signaling pathway; and positive regulation of epidermis development. Predicted to be located in plasma membrane. Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.09546581).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ELAPOR2 | NM_001142749.3 | c.3085A>G | p.Ile1029Val | missense_variant | 22/22 | ENST00000450689.7 | NP_001136221.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ELAPOR2 | ENST00000450689.7 | c.3085A>G | p.Ile1029Val | missense_variant | 22/22 | 5 | NM_001142749.3 | ENSP00000413445 | P2 | |
ELAPOR2 | ENST00000444627.5 | c.2872A>G | p.Ile958Val | missense_variant | 22/22 | 5 | ENSP00000397377 | A2 | ||
ELAPOR2 | ENST00000416314.5 | c.2584A>G | p.Ile862Val | missense_variant | 21/21 | 2 | ENSP00000402390 | A2 | ||
ELAPOR2 | ENST00000394714.6 | c.*2357A>G | 3_prime_UTR_variant, NMD_transcript_variant | 20/20 | 5 | ENSP00000378203 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152048Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
11
AN:
152048
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000440 AC: 11AN: 250042Hom.: 0 AF XY: 0.0000444 AC XY: 6AN XY: 135260
GnomAD3 exomes
AF:
AC:
11
AN:
250042
Hom.:
AF XY:
AC XY:
6
AN XY:
135260
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000426 AC: 62AN: 1456002Hom.: 0 Cov.: 27 AF XY: 0.0000455 AC XY: 33AN XY: 724832
GnomAD4 exome
AF:
AC:
62
AN:
1456002
Hom.:
Cov.:
27
AF XY:
AC XY:
33
AN XY:
724832
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152048Hom.: 0 Cov.: 32 AF XY: 0.0000943 AC XY: 7AN XY: 74256
GnomAD4 genome
AF:
AC:
11
AN:
152048
Hom.:
Cov.:
32
AF XY:
AC XY:
7
AN XY:
74256
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
3
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 01, 2021 | The c.3085A>G (p.I1029V) alteration is located in exon 22 (coding exon 22) of the KIAA1324L gene. This alteration results from a A to G substitution at nucleotide position 3085, causing the isoleucine (I) at amino acid position 1029 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T;T
M_CAP
Benign
T
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;.;.
MutationTaster
Benign
D;D;D;N
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N
REVEL
Benign
Sift
Uncertain
D;D;D
Sift4G
Benign
T;T;T
Polyphen
B;.;.
Vest4
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at